Tetrahydrobiopterin Supplementation Enhances Carotid Artery Compliance in Healthy Older Men: A Pilot Study

1] Department of Integrative Physiology, University of Colorado, Boulder, Colorado, USA [2] Department of Health and Human Physiology, University of Iowa, Iowa City, Iowa, USA.
American Journal of Hypertension (Impact Factor: 2.85). 06/2012; 25(10):1050-4. DOI: 10.1038/ajh.2012.70
Source: PubMed


We performed a pilot study to test the hypothesis that acute oral ingestion of tetrahydrobiopterin (BH(4)), a key cofactor modulating vascular nitric oxide (NO) synthase activity, improves large elastic artery stiffness with aging in men.Methods
Healthy older (63 ± 2 years; n = 8) and young (age 25 ± 1 years; n = 6) men were studied 3 h after ingestion of BH(4) (10 mg·kg(-1) body weight) or placebo on separate days in a randomized, placebo-controlled, double-blind study.ResultsBaseline carotid artery compliance was 37% lower (0.17 ± 0.02 vs. 0.22 ± 0.02 mm/mm Hg·10(-1)) and β-stiffness was 42% higher (7.3 ± 1.1 vs. 4.2 ± 0.5 AU) in the older men (both P < 0.05). BH(4) ingestion markedly increased circulating BH(4) concentrations in both groups (17-19-fold, P < 0.05), but increased compliance (+39% to 0.23 ± 0.02 mm/mm Hg(.)10(-1), P < 0.01) and decreased β-stiffness index (-27% to 5.3 ± 0.7 AU, P < 0.01) only in the older men. BH(4) also reduced carotid systolic blood pressure (SBP) in the older men (P < 0.05).Conclusions
These preliminary results support the possibility that limited BH(4) bioavailability contributes to impaired carotid artery compliance in healthy older men. Further studies are needed to determine if increasing BH(4) bioavailability though oral BH(4) supplementation may have therapeutic efficacy for improving large elastic artery compliance and reducing central SBP with aging.American Journal of Hypertension 2012; doi:10.1038/ajh.2012.70.

Download full-text


Available from: Allison E DeVan, Oct 07, 2014
35 Reads
  • Source
    • "Nevertheless, an effect of these confounders would be excluded by the stepwise multiple regression analysis (Table 4), showing an independent effect of age in the reduction of both NOx FSR and ASR. The reduced NO availability in aged people may be enhanced by antioxidants and by tetrahydrobiopterin, which prevent NOS uncoupling as well as NO use as a scavenger of oxygen radicals (26–28). Although the measurement of circulating antioxidants was beyond the purpose of our study, it would be interesting to test their effects in vivo on NOx kinetics. "
    [Show abstract] [Hide abstract]
    ABSTRACT: We tested the effects of insulin, on production of NO-related substances (nitrites and nitrates, NOx) following 15N-arginine iv infusion, and on ADMA and SDMA concentrations, in conditions reportedly associated with altered NO availability, i.e. ageing, hypertension, hypercholesterolemia, and Type-2 Diabetes (T2DM). A total of 26 male subjects (age: 23-71 yrs, BMI: 23-33 kg/m2), some of them affected by mixed pathologic features, were enrolled. NOx fractional synthesis rate (FSR) was lower in elderly (p<0.015) and T2DM subjects p<0.03), than in matched controls. Hyperinsulinemia generally increased both NOx FSR and ASR (Absolute Synthesis Rate), and reduced NOx, ADMA and SDMA concentrations. Insulin-sensitivity was impaired only in T2DM. Using simple linear regression analysis across all subjects, age was inversely correlated with both NOx FSR (R2 = 0.23, p<0.015) and ASR (R2 = 0.21, p<0.02). NOx FSR inversely correlated with both ADMA and SDMA. Using multiple regression analysis and various models, NOx FSR remained inversely associated with age and ADMA, whereas ASR was inversely associated with age and diabetes. No association with insulin sensitivity was found. We conclude that whole-body NOx production is decreased in ageing and T2DM. Age, ADMA concentration and T2DM, but not insulin-resistance, appear as negative regulators of whole-body NOx production.
    Diabetes 03/2013; 62(8). DOI:10.2337/db12-1127 · 8.10 Impact Factor
  • Source
    American Journal of Hypertension 04/2013; 26(4):580. DOI:10.1093/ajh/hpt004 · 2.85 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Functional constitutive nitric oxide synthase (NOS) and its cofactor tetrahydrobiopterin(BH4) are required for full reflex cutaneous vasodilation, and are attenuated in primary aging. Acute locally-administered BH4 increases reflex vasodilation through NO-dependent mechanisms in aged skin. We hypothesized that oral sapropterin (Kuvan®, shelf-stable pharmaceutical formulation of BH4) would augment reflex vasodilation in aged human skin during hyperthermia. Nine healthy human subjects (76±1years) ingested sapropterin (10mg/kg) or placebo in a randomized double-blind crossover design. Venous blood samples were collected prior to, and 3h following, ingestion of sapropterin for measurement of plasma BH4. Three intradermal microdialysis fibers were placed in the forearm skin for local delivery of 1)lactated Ringers solution, 2)10mM BH4, and 3)20mM N(G)-nitro-L-arginine methyl ester (L-NAME) to inhibit NOS. Red cell flux was measured at each site by laser-Doppler flowmetry (LDF) as reflex vasodilation was induced using a water-perfused suit. At 1°C rise in oral temperature, mean body temperature was clamped and 20mM L-NAME was perfused at each site. Cutaneous vascular conductance was calculated (CVC=LDF/MAP) and expressed as a percentage of maximum (%CVCmax;28mM sodium nitroprusside and local heat,43°C). Plasma concentrations of BH4 were significantly elevated 3h after ingestion of sapropterin (0h:19.1±2pmol/mlvs.3h:43.8±3pmol/ml;p<0.001). Sapropterin increased NO-dependent vasodilation at control site (placebo:14±1%CVCmaxvs.sapropterin:25±4%CVCmax;p=0.004). Local BH4 administration increased NO-dependent vasodilation compared to control in placebo trials only (control:14±1%CVCmaxvs.BH4-treated:24±3%CVCmax;p=0.02). These data suggest oral sapropterin increases bioavailable BH4 in aged skin microvasculature sufficiently to increase NO synthesis through NOS and that sapropterin may be a viable intervention to increase skin blood flow during hyperthermia in healthy aged humans.
    Journal of Applied Physiology 06/2013; 115(7). DOI:10.1152/japplphysiol.00481.2013 · 3.06 Impact Factor
Show more